A once-weekly acylated 31-amino-acid GLP-1 receptor agonist (CAS 910463-68-2). A 2-aminoisobutyric-acid substitution at position 2 resists DPP-4 cleavage, and a C-18 fatty-diacid side chain at Lys26 binds albumin to extend half-life to ~7 days. FDA-approved by Novo Nordisk as Ozempic (subcutaneous, type 2 diabetes), Rybelsus (oral, type 2 diabetes), and Wegovy (subcutaneous, chronic weight management including cardiovascular risk reduction).
For research purposes only. Not medical advice.
Modern Research Peptides currently lists Semaglutide at $2.33/mg, the lowest indexed price across 16 tracked research peptide vendors.
Semaglutide ranges from $2.33/mg to $13.80/mg across 37 listings from 16 research peptide vendors, normalized to USD per milligram and refreshed daily.
16 research peptide vendors currently list Semaglutide on PeptideScouter, with 15 in stock right now. We track 37 active listings across size and kit variants.
Semaglutide's CAS Registry Number is 910463-68-2. It is also sold as S-GLP1, GLA-1 SM, GLP1-Sema.